Literature DB >> 24074853

FOXO in the hole: leveraging GWAS for outcome and function.

Peter K Gregersen1, Nataly Manjarrez-Orduño.   

Abstract

GWAS studies of autoimmune disorders have yielded hundreds of replicated associations, but moving from genetic association to functional studies with potential clinical relevance is a challenge. Leveraging GWAS data, Lee et al. now identify FOXO3 activity as predictive of disease severity in Crohn's disease and rheumatoid arthritis as well as malaria, likely by acting through regulation of cytokine production in monocytes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24074853     DOI: 10.1016/j.cell.2013.08.050

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  6 in total

Review 1.  Rheumatoid arthritis in 2013. Translational medicine in RA: time for change.

Authors:  Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2014-01-14       Impact factor: 20.543

2.  Identification of a Novel Role for Foxo3 Isoform2 in Osteoclastic Inhibition.

Authors:  Cheng Xu; Gregory J Vitone; Kazuki Inoue; Courtney Ng; Baohong Zhao
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

3.  RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.

Authors:  Christine H Miller; Sinead M Smith; Mahmoud Elguindy; Tuo Zhang; Jenny Z Xiang; Xiaoyu Hu; Lionel B Ivashkiv; Baohong Zhao
Journal:  J Immunol       Date:  2016-05-09       Impact factor: 5.422

4.  Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.

Authors:  Kazuki Inoue; Xiaoyu Hu; Baohong Zhao
Journal:  FASEB J       Date:  2019-12-23       Impact factor: 5.191

Review 5.  The Rough Guide to Monocytes in Malaria Infection.

Authors:  Amaya Ortega-Pajares; Stephen J Rogerson
Journal:  Front Immunol       Date:  2018-12-07       Impact factor: 7.561

Review 6.  Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients.

Authors:  Sung Chul Park; Yoon Tae Jeen
Journal:  Cells       Date:  2019-05-01       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.